6-[18F]fluoro-L-dopa metabolism in living human brain: a comparison of six analytical methods. (Q48366038)

11 February 2018

title

6-[18F]fluoro-L-dopa metabolism in living human brain: a comparison of six analytical methods. (English)

1 reference

11 February 2018

6

Gjedde A

1 reference

11 February 2018

4

Cumming P

1 reference

11 February 2018

author name string

Hoshi H

1

1 reference

11 February 2018

Kuwabara H

2

1 reference

11 February 2018

Léger G

3

1 reference

11 February 2018

Guttman M

5

1 reference

11 February 2018

publication date

1 January 1993

1 reference

11 February 2018

Journal of Cerebral Blood Flow & Metabolism

published in

1 reference

11 February 2018

volume

13

1 reference

11 February 2018

issue

1

1 reference

11 February 2018

page(s)

57-69

1 reference

11 February 2018

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

cites work

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1993.8

Determination of plasma [18F]-6-fluorodopa during positron emission tomography: elimination and metabolism in carbidopa treated subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1993.8

The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1993.8

Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1993.8

"On-Off" Phenomena Related to High Plasma Levodopa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1993.8

The metabolism of [18F]6-fluoro-L-3,4-dihydroxyphenylalanine in the hooded rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1993.8

Kinetics of in vitro decarboxylation and the in vivo metabolism of 2-18F- and 6-18F-fluorodopa in the hooded rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1993.8

Distribution and kinetics of 3-O-methyl-6-[18F]fluoro-L-dopa in the rhesus monkey brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1993.8

MRI-PET correlation in three dimensions using a volume-of-interest (VOI) atlas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1993.8

Cerebral metabolism of 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine in the primate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1993.8

Dopamine visualized in the basal ganglia of living man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1993.8

Calculation of cerebral glucose phosphorylation from brain uptake of glucose analogs in vivo: a re-examination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1993.8

Dopa decarboxylase activity of the living human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1993.8

Parkinsonism: onset, progression, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1993.8

Kinetics and modeling of L-6-[18F]fluoro-dopa in human positron emission tomographic studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1993.8

Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1993.8

Use of [11C]aminocyclohexanecarboxylate for the measurement of amino acid uptake and distribution volume in human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1993.8

Michaelis-Menten constraints improved cerebral glucose metabolism and regional lumped constant measurements with [18F]fluorodeoxyglucose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1993.8

Human striatal L-dopa decarboxylase activity estimated in vivo using 6-[18F]fluoro-dopa and positron emission tomography: error analysis and application to normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1993.8

18F‐6‐Fluorodopa PET scanning in Parkinson's disease after selective COMT inhibition with nitecapone (OR‐462)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1993.8

Inhibition of L-[18F]fluorodopa uptake into human brain by amino acids demonstrated by positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1993.8

Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1993.8

The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1993.8

Nigrostriatal function in humans studied with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1993.8

L-6-[18F]fluoro-dopa metabolism in monkeys and humans: biochemical parameters for the formulation of tracer kinetic models with positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1993.8

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1993.8

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1993.8

Saturable retention of vasopressin by hippocampus vessels in vivo, associated with inhibition of blood-brain transfer of large neutral amino acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1993.8

Blood-brain transfer and metabolism of 6-[18F]fluoro-L-dopa in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1993.8

3-0-Methyldopa uptake and inhibition of L-dopa at the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1993.8

Performance evaluation of the PC-2048: a new 15-slice encoded-crystal PET scanner for neurological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1993.8

7 January 2021

The preparation of [18F]5-fluoro-DOPA with reactor-produced fluorine-18

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1993.8

7 January 2021

Central dopaminergic pathways in hemiparkinsonism examined by positron emission tomography

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1993.8

7 January 2021

High‐ and Low‐Affinity Transport of D‐Glucose from Blood to Brain

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1993.8

7 January 2021

Brain kinetics of L-[?-11 C]DOPA in humans studied by positron emission tomography

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1993.8

7 January 2021

Regional brain kinetics of 6-fluoro-(beta-11C)-L-dopa and (beta-11C)-L-dopa following COMT inhibition. A study in vivo using positron emission tomography

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1993.8

7 January 2021

Amino acid assignment to one of three blood-brain barrier amino acid carriers

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1993.8

7 January 2021

Identifiers

DOI

10.1038/JCBFM.1993.8

1 reference

11 February 2018

PubMed ID

8417011

1 reference

11 February 2018